Legal Representation
Attorney
Jenevieve Maerker
USPTO Deadlines
Next Deadline
558 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-02-02)
Due Date
February 02, 2027
Grace Period Ends
August 02, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
45 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 17, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 1, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 1, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 12, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 8, 2021 | ATRQ | I | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED | Loading... |
| Apr 8, 2021 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| Feb 26, 2021 | CRTP | C | REG. CANCELLED - RESTORED TO PENDENCY | Loading... |
| Feb 19, 2021 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Feb 2, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 2, 2021 | RCII | I | REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED | Loading... |
| Jan 1, 2021 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Dec 31, 2020 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Dec 29, 2020 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Dec 28, 2020 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Dec 28, 2020 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Dec 24, 2020 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| Jul 3, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 2, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jul 2, 2020 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jun 18, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 18, 2020 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Dec 21, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 19, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 19, 2019 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Dec 19, 2019 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jun 12, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 10, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 10, 2019 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jun 10, 2019 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Dec 20, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 18, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 18, 2018 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Dec 18, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 15, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 13, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 13, 2018 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jun 13, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 26, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 31, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 31, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 11, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 20, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 20, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 28, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 24, 2017 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for the treatment of cancer, MRSA, sepsis, immunological diseases and disorders, and age-related diseases and disorders; drug delivery agents as a featured component of pharmaceuticals for the treatment of cancer, MRSA, sepsis, immunological diseases and disorders, and age-related diseases and disorders
First Use Anywhere:
Dec 18, 2020
First Use in Commerce:
Dec 18, 2020
Class 010
Medical apparatus and units for dosing, namely, drug delivery devices and systems; medical apparatus for introducing pharmaceutical preparations into the human body
First Use Anywhere:
Dec 18, 2020
First Use in Commerce:
Dec 18, 2020
Classification
International Classes
005
010